Better Blood Pressure Control....Better Life.
Board of Directors
Proven management team, strong intellectual property.
Sung Pak,CEO & Board Member

Sung is a seasoned business, thought, and civic leader with 30 years of experience with a wide variety of organizations, including start-ups, Fortune 500 multi-nationals, government-owned/sponsored entities, and non-profit social enterprises.

His business experience includes holding varied executive (VP of R&D, VP of Operations, and GM), advisor, consultant, and board member positions with more than 25 life sciences companies, including Johnson & Johnson, Baxter, Covidien, B Braun, and Medtronic, and more than 10 information technology companies, including Motorola, IBM, Scantron, and Hewlett Packard. His functional experience includes business development, marketing, sales, R&D, operations, quality, human resources, and technical support. He has extensive international experience setting up organizations across various countries and preparing them for successful market launch and growth. Sung has personally launched more than 15 products and services that resulted in combined revenue in excess of $300M.

Sung is also a thought leader. He has taught extension courses at UCLA, given lectures at many leading universities, and published 32 journal papers and two book chapters. He is named on seven granted and five pending patents. He is quoted in Fortune, Business Week, Software Business, and the Orange Country Register. He served as an Advisory Board Member of Gumi Medical Electronic Research Institute, a medical device incubator funded by the Korean government in the “Silicon Valley of Korea.”

Sung’s civic leadership responsibilities includes: Advisory Board Member of the Salvation Army, Vice Chair of the KPCA Board, and Elder of a rapidly growing church.

Sung is currently a Managing Partner at Value Creation Institute (VCI), a leading decision analytics and process re-engineering company offering a full suite of services and customized decision support tools. He is also a board member of Ektropia, a data analytics software startup.

Sung holds an MBA from the Anderson School of Management at UCLA in addition to MS and BS degrees in materials science from the University of Washington.

SHAWN MOADDEB,CHAIRMAN

Founder & Chairman of Adventus Ventures Corp, medical technology incubator and entrepreneur with strong background with both start-up and large established organizations (Johnson & Johnson, St. Jude Medical).

Shawn has held various leadership position; CEO, senior executive, boardmember, and co-founded multiple medical device companies with several successful exists: EP Dynamics, Lavita Technologies, Renal Dynamics, Vessix Vascular, Ellipse Technologies, & Savona Therapeutics, Oncogenics Guidance Systems.

RANDY WERNETH,BOARD MEMBER

Randy is a seasoned executive with 25 years of experience in both small entrepreneurial and Fortune 500 corporations in the medical device industry.

Randy is CEO & President of CardioCorX. Randy is also board member at Adventus Ventures and founder of meridian INNOVAYIONS. Prior to that Randy was CEO and founder of Acutus Medical, Randy successfully started Ablation Frontiers (acquired by Medtronic), LeanTherapeutics, CryoTherapeutics and CardioStream (acquired technology through private deal).

TROY BARRING,BOARD MEMBER

Troy has held a variety of senior leadership positions in both small and large companies in General Management, Sales & Marketing, R&D and Operations.

Troy has more than 10 years of General Manager/VP Sales & Marketing experience at Fortune 500 companies. Previous C-level leadership at Avita Medical, Orthozon Technologies and North American Scientific. Troy also held various senior leadership positions at Baxter Healthcare, Johnson & Johnson and Boston Scientific Corporation.

Dan L. Dearen,BOARD MEMBER

Dan has over 25 years of experience building healthcare technology companies.

Dan is currently the President and CFO of Axonics Modulation Technologies, a medical device company treating overactive bladder. Previously COO & CFO of Vessix Vascular and General Manager responsible for post-acquisition integration after the acquisition by Boston Scientific.

Shinya Miike,Board Advisor

Shinya has the 25-year experience in medical device business. He invested in several Venture companies who develop various new medical devices with hands on operations.

Shinya is currently CEO & President of Neuroceuticals, Inc, privately held company supporting overseas start-up medical device company to enter into Japanese market by investing, and setting up marketing strategy in Japan including obtaining government approval (PMDA approval).

Roy Tanaka,BOARD MEMBER

Roy is a member of the Boards of Directors of VytronUS, EPIX Therapeutics, and BioSig Technologies, medical device start-ups developing technologies for treating atrial fibrillation, a cardiac arrhythmia.

He has also served on the boards of Volcano Corporation, a company that develops intravascular ultrasound that aid in the diagnosis and treatment of vascular and structural heart disease, TomoTherapy Incorporated, an advanced radiation therapy company that markets systems for the treatment of a wide range of cancer types, and Coherex, an atrial appendage closure device company. Prior to his retirement, Roy was the Worldwide President of Biosense Webster, a Johnson & Johnson Company, from March, 2004 until his retirement in September, 2008. Biosense Webster is the market and technology leader in the field of electrophysiology, a subspecialty of cardiology dedicated to the diagnosis and treatment of heart rhythm disorders.

Reza Allamezadeh,MD Chief Medical Officer

Reza is double board certified in Nephrology and Internal Medicine with Subspecialty training in Kidney Transplant and Pancreas Transplant. Reza’s expertise includes Hypertension and treating patients with various level of hypertension.

Reza completed his residency in Internal Medicine at Kern Medical Center. He subsequently completed his nephrology fellowship at UCI Medical Center where he scored the highest in the nationwide among all other nephrology follows on the nephrology exam. After his fellowship training at UCI, Reza completed his subspecialty training in kidney transplant & pancreas transplant at UCLA Medical Center. While he was at UCLA he worked on over 300 transplant patients and also received high honors and recognition for his presentation at the American Society of Transplant conference. Reza is affiliated with multiple hospitals as well as private practice in Mission Viejo, CA.